412 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Bought by Principal Securities Inc.

Principal Securities Inc. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 412 shares of the company’s stock, valued at approximately $55,000.

A number of other large investors also recently bought and sold shares of ALAB. Tidal Investments LLC raised its holdings in shares of Astera Labs by 81.8% during the third quarter. Tidal Investments LLC now owns 45,298 shares of the company’s stock valued at $2,373,000 after acquiring an additional 20,388 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Astera Labs during the third quarter worth $530,000. Avior Wealth Management LLC purchased a new stake in Astera Labs during the 3rd quarter valued at about $361,000. Maverick Capital Ltd. lifted its stake in Astera Labs by 16.0% in the 3rd quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock worth $60,575,000 after purchasing an additional 159,480 shares in the last quarter. Finally, Bank of Hawaii purchased a new stake in Astera Labs in the 3rd quarter valued at $1,409,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB opened at $75.75 on Friday. Astera Labs, Inc. has a 1-year low of $36.22 and a 1-year high of $147.39. The stock has a market cap of $12.28 billion and a PE ratio of -43.79. The firm has a fifty day moving average price of $113.02 and a 200 day moving average price of $85.95.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. As a group, equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $87.46, for a total value of $4,373,000.00. Following the transaction, the general counsel now owns 191,209 shares of the company’s stock, valued at approximately $16,723,139.14. The trade was a 20.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jitendra Mohan sold 350,680 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total value of $31,389,366.80. Following the sale, the chief executive officer now owns 2,353,655 shares of the company’s stock, valued at $210,675,659.05. This trade represents a 12.97 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 702,190 shares of company stock valued at $66,714,568 over the last quarter.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ALAB shares. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Roth Mkm boosted their target price on Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Stifel Nicolaus increased their target price on shares of Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, January 6th. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $140.00 target price on shares of Astera Labs in a research note on Tuesday, February 11th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $115.33.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.